HIP REPLACEMENT "BENCHMARK" IS CEMENTED FEMORAL STEM WITH CEMENTLESS ACETABULAR HEAD, NIH CONSENSUS PANEL CONCLUDES; HIP REGISTRIES SUGGESTED
This article was originally published in The Gray Sheet
Executive Summary
A hybrid hip replacement comprised of a cemented femoral stem and a cementless acetabular head should be the "gold standard" in the design of primary hip replacement prostheses, a National Institutes of Health consensus panel suggested at the conclusion of a Sept. 12-14 meeting in Bethesda, Maryland. Citing the efficacy and long-term durability of the respective components, the group concluded in its consensus statement that "the benchmark for the primary total hip is a cemented femoral component using new cement techniques, and a cementless acetabular component."
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.